Quantitative cell-based bioassays for therapeutic development targeting immune checkpoint and co-stimulatory receptors

被引：0
|
作者：
Grailer, Jamison
Stecha, Pete
Wang, Jun
Hartnett, Jim
Fan, Frank
Cong, Mei
Cheng, Zhi-jie Jey
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-4878
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4878
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Quantitative cell-based assays for characterization of antibodies targeting co-stimulatory immune checkpoint receptors
    Gilden, Julia K.
    Wang, Jun
    Beck, Michael
    Grailer, Jamison
    Hartnett, Jim
    Fan, Frank
    Cong, Mei
    Cheng, Zhe-jie Jey
    CANCER RESEARCH, 2017, 77
  • [2] Quantitative cell-based reporter bioassays for functional characterization of immunotherapeutic biologics targeting co-stimulatory and co-inhibitory immune checkpoint receptors
    Grailer, Jamison
    Gilden, Julia
    Stecha, Pete
    Garvin, Denise
    Wang, Jun
    Beck, Michael
    Hartnett, Jim
    Krishnan, Gopal
    Fan, Frank
    Cong, Mei
    Cheng, Zhi-jie Jey
    CANCER RESEARCH, 2020, 80 (16)
  • [3] QUANTITATIVE CELL-BASED BIOASSAYS TO ADVANCE IMMUNOTHERAPY PROGRAMS TARGETING IMMUNE CHECKPOINT RECEPTORS
    Grailer, Jamison
    Gilden, Julia
    Stecha, Pete
    Garvin, Denise
    Wang, Jun
    Beck, Michael
    Hartnett, Jim
    Krishnan, Gopal
    Fan, Frank
    Cong, Mei
    Cheng, Zhi-Jie
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A468 - A468
  • [4] Quantitative cell-based bioassays to advance immunotherapy programs targeting immune checkpoint receptors
    Ott, Vanessa
    Grailer, Jamison
    Wang, Jun
    Gilden, Julia
    Stecha, Pete
    Garvin, Denise
    Beck, Michael
    Hartnett, Jim
    Fan, Frank
    Cong, Mei
    Cheng, Zhi-jie Jey
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [5] Quantitative cell-based bioassays to advance immunotherapy programs targeting immune checkpoint receptors
    Grailer, Jamison
    Gilden, Julia
    Stecha, Pete
    Garvin, Denise
    Wang, Jun
    Beck, Michael
    Hartnett, Jim
    Krishnan, Gopal
    Fan, Frank
    Cong, Mei
    Cheng, Zhi-jie Jey
    CANCER RESEARCH, 2019, 79 (13)
  • [6] MoA-based reporter bioassays enable quantitative potency determination for therapeutic biologics targeting co-stimulatory and co-inhibitory immune checkpoint receptors.
    Grailer, Jamison
    Gilden, Julia
    Stecha, Pete
    Garvin, Denise
    Wang, Jun
    Beck, Michael
    Hartnett, Jim
    Fan, Frank
    Cong, Mei
    Cheng, Zhi-Jie Jey
    CANCER RESEARCH, 2021, 81 (13)
  • [7] Quantitative cell-based bioassays to advance individual or combination immune checkpoint immunotherapy
    Grailer, Jamison
    Gilden, Julia
    Stecha, Pete
    Garvin, Denise
    Hartnett, Jim
    Fan, Frank
    Cong, Mei
    Cheng, Zhi-Jie Jey
    CANCER RESEARCH, 2018, 78 (13)
  • [8] Quantitative cell-based bioassays to advance individual or combination immune checkpoint immunotherapy
    Grailer, Jamison
    Stecha, Pete
    Garvin, Denise
    Hartnett, Jim
    Fan, Frank
    Cong, Mei
    Cheng, Zhi-Jie Jey
    CANCER RESEARCH, 2017, 77
  • [9] DELTA-24-RGDOX: TARGETING CO-STIMULATORY IMMUNE CHECKPOINT PROTEINS WITH ONCOLYTIC ADENOVIRUSES
    Jiang, Hong
    Lang, Frederick
    Fan, Xuejun
    Gumin, Joy
    Bover, Laura
    Clise-Dwyer, Karen
    Toniatti, Carlo
    Ruisaard, Kathryn
    Conrad, Charles
    Vence, Luis
    Gomez-Manzano, Candelaria
    Fueyo, Juan
    NEURO-ONCOLOGY, 2014, 16
  • [10] Targeting Co-Stimulatory Receptors of the TNF Superfamily for Cancer Immunotherapy
    Dafne Müller
    BioDrugs, 2023, 37 : 21 - 33
12345